Residual Adrenal Function After Multivisceral Resection With Adrenalectomy in Adult Patients.

Abstract

Importance:

The risk of developing adrenal insufficiency (AI) following adrenalectomy has been insufficiently studied in the context of multivisceral resection (MVR).

Objective:

To evaluate the incidence of AI in patients undergoing MVR with en bloc adrenalectomy.

Design, Setting, and Participants:

Prospective observational longitudinal study in a single referral center including 56 consecutive adult patients undergoing retroperitoneal sarcoma surgery from June 2019 to August 2020. Those who were candidates for MVR with en bloc adrenalectomy and had no preexisting adrenal impairment were considered eligible. Of these, 4 individuals were excluded because they did not receive adrenalectomy at the time of surgery and 2 because they were not considered evaluable for the main end point. Follow-up was set at 4 months after surgery, and 49 patients completed follow-up. Data were analyzed from October 2020 to September 2021.

Exposures:

Diagnosis of AI was determined by low-dose (1 μg) adrenocorticotropic hormone (ACTH) stimulation test with a threshold of 20 μg/dL in blood samples retrieved 30 and 60 minutes after stimulation. ACTH test was repeated on postoperative days 1 and 10 and at 4 months' follow-up.

Main Outcome and Measures:

The primary end point was incidence and relevance of AI after MVR. Secondary end points were associations with patient- and tumor-related factors, impact on perioperative hemodynamic management, and association with postoperative morbidity and mortality.

Results:

Fifty patients (26 female; median [IQR] age, 59 [46-67] years) were evaluable. Incidence of AI was 64% (32 of 50 patients) in the early postoperative period and 38.5% (15 of 39 patients) at follow-up. Patients with AI showed lower postoperative cortisol values. Factors associated with risk of AI at univariate analysis were high American Society of Anesthesiologists score (odds ratio [OR], 0.31; 95% CI, 0.14-0.48) and high malignancy grade (OR, 0.35; 95% CI, 0.24-0.46). Clinical outcomes not associated with AI included morbidity, mortality, reoperation rate, admission to intensive care unit, length of intensive care unit stay, total hospital stay, and long-term quality of life.

Conclusions and Relevance:

In this study, AI after MVR with en bloc adrenalectomy was frequent, even in patients with adequate preoperative adrenal function. Despite this, adrenalectomy can be safely performed. Patients at risk should be monitored in the long term to exclude underrated impairment of adrenal function.

• Authors: Marco Fiore, Marco Baia, Lorenzo Conti, Federico Piccioni, Luigi Mariani, Sandro Pasquali, Ettore Seregni, Gabriele Maltese, Mauro Galizia, Stefano Radaelli, Alessandro Maria Villa, Franco Valenza, Alessandro Gronchi
• Journal: JAMA surgery (JAMA Surg) Vol. 157 Issue 5 Pg. 415-423 (05 01 2022) ISSN: 2168-6262 [Electronic] United States
• PMID: 35195679 (Publication Type: Journal Article, Observational Study)

Chemical References

• Adrenocorticotropic Hormone

Topics

• Adrenal Insufficiency (epidemiology, etiology)
• Adrenalectomy (adverse effects)
• Adrenocorticotropic Hormone
• Adult
• Female
• Humans
• Longitudinal Studies
• Middle Aged
• Quality of Life